Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Prime Medicine, Inc. | 10%+ Owner | Common Stock | 10.1M | $151M | $14.97 | Jun 21, 2023 | By GV 2019, L.P. |
IonQ, Inc. | Former 10% Group Member | Common Stock | 4.56M | $60.2M | $13.21 | Apr 11, 2022 | By GV 2019 L.P. |
Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 4.47M | $44.7M | $10.00 | Jun 21, 2021 | By GV 2019 L.P. |
Prime Medicine, Inc. | 10%+ Owner | Common Stock | 1.76M | $26.4M | $14.97 | Jun 20, 2023 | By GV 2021, L.P. |
Prime Medicine, Inc. | 10%+ Owner | Common Stock | 0 | $14.97 | Jun 21, 2023 | By Alphabet Holdings LLC | |
Verve Therapeutics, Inc. | 10%+ Owner | Series A-2 Preferred Stock | 0 | Jun 21, 2021 | By GV 2019 L.P. | ||
Verve Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jun 21, 2021 | By GV 2019 L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRME | Prime Medicine, Inc. | Jun 20, 2023 | 4 | -$848K | 4 | Jun 22, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | Jun 15, 2023 | 4 | -$1.09M | 4 | Jun 20, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | Jun 13, 2023 | 4 | -$856K | 4 | Jun 15, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | Jun 9, 2023 | 4 | -$467K | 4 | Jun 13, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | Jun 7, 2023 | 4 | -$333K | 4 | Jun 9, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | Jun 5, 2023 | 4 | -$885K | 4 | Jun 7, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 31, 2023 | 5 | -$876K | 4 | Jun 2, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 26, 2023 | 4 | -$403K | 4 | May 31, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 24, 2023 | 4 | -$418K | 4 | May 26, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 22, 2023 | 4 | -$1.89M | 4 | May 24, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 18, 2023 | 5 | -$1.23M | 4 | May 22, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 16, 2023 | 2 | -$829K | 4 | May 18, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 12, 2023 | 2 | -$2.36M | 4 | May 16, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 10, 2023 | 3 | -$1.58M | 4 | May 12, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | May 8, 2023 | 2 | -$5.95M | 4 | May 10, 2023 | 10%+ Owner |
PRME | Prime Medicine, Inc. | Oct 24, 2022 | 5 | $13.6M | 4 | Oct 26, 2022 | 10%+ Owner |
PRME | Prime Medicine, Inc. | Oct 19, 2022 | 0 | $0 | 3 | Oct 19, 2022 | 10%+ Owner |
IONQ | IonQ, Inc. | Apr 11, 2022 | 0 | $0 | 4 | Apr 12, 2022 | Former 10% Group Member |
IONQ | IonQ, Inc. | Sep 30, 2021 | 0 | $0 | 3/A | Apr 8, 2022 | 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 21, 2021 | 4 | $0 | 4 | Jun 22, 2021 | 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | 10%+ Owner |